Clinical trial
The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous…
NCT00005660 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00005660 |
|---|---|
| Title | The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases |
| Official title | The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Basal Cell Carcinoma, Keratosis Palmaris et Plantaris, Psoriasis |
| Enrollment | 130 |
| Start date | Oct 1, 1977 |
| Completion | Nov 1, 2001 |
| First posted | May 15, 2000 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: